AU2011258295B2 - Methods, substrates, and systems useful for cell seeding of medical grafts - Google Patents

Methods, substrates, and systems useful for cell seeding of medical grafts Download PDF

Info

Publication number
AU2011258295B2
AU2011258295B2 AU2011258295A AU2011258295A AU2011258295B2 AU 2011258295 B2 AU2011258295 B2 AU 2011258295B2 AU 2011258295 A AU2011258295 A AU 2011258295A AU 2011258295 A AU2011258295 A AU 2011258295A AU 2011258295 B2 AU2011258295 B2 AU 2011258295B2
Authority
AU
Australia
Prior art keywords
cells
substrate
cell
cell growth
growth substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011258295A
Other languages
English (en)
Other versions
AU2011258295A1 (en
Inventor
Neal E. Fearnot
Michael C. Hiles
Ronald Jankowski
Chad E. Johnson
Thomas Payne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cook Biotech Inc
Muffin Inc
Original Assignee
Cook Biotech Inc
Muffin Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cook Biotech Inc, Muffin Inc filed Critical Cook Biotech Inc
Publication of AU2011258295A1 publication Critical patent/AU2011258295A1/en
Assigned to COOK BIOTECH INCORPORATED, MUFFIN INCORPORATED reassignment COOK BIOTECH INCORPORATED Request for Assignment Assignors: COOK BIOTECH INCORPORATED, COOK MEDICAL TECHNOLOGIES LLC, MUFFIN INCORPORATED
Application granted granted Critical
Publication of AU2011258295B2 publication Critical patent/AU2011258295B2/en
Priority to AU2015202093A priority Critical patent/AU2015202093B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3808—Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3826—Muscle cells, e.g. smooth muscle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00—Bioreactors or fermenters specially adapted for specific uses
    • C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/02—Form or structure of the vessel
    • C12M23/06—Tubular
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00—Constructional details, e.g. recesses, hinges
    • C12M23/34—Internal compartments or partitions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14—Scaffolds; Matrices
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/26—Materials or treatment for tissue regeneration for kidney reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/28—Materials or treatment for tissue regeneration for liver reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/30—Materials or treatment for tissue regeneration for muscle reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Sustainable Development (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Clinical Laboratory Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AU2011258295A 2010-05-25 2011-05-25 Methods, substrates, and systems useful for cell seeding of medical grafts Active AU2011258295B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2015202093A AU2015202093B2 (en) 2010-05-25 2015-04-23 Methods, substrates, and systems useful for cell seeding of medical grafts

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34813510P 2010-05-25 2010-05-25
US61/348,135 2010-05-25
PCT/US2011/037897 WO2011150055A2 (en) 2010-05-25 2011-05-25 Methods, substrates, and systems useful for cell seeding of medical grafts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2015202093A Division AU2015202093B2 (en) 2010-05-25 2015-04-23 Methods, substrates, and systems useful for cell seeding of medical grafts

Publications (2)

Publication Number Publication Date
AU2011258295A1 AU2011258295A1 (en) 2013-01-10
AU2011258295B2 true AU2011258295B2 (en) 2015-01-29

Family

ID=44343129

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011258295A Active AU2011258295B2 (en) 2010-05-25 2011-05-25 Methods, substrates, and systems useful for cell seeding of medical grafts

Country Status (7)

Country Link
US (5) US9115336B2 (cg-RX-API-DMAC7.html)
EP (2) EP2575913B1 (cg-RX-API-DMAC7.html)
JP (3) JP5947790B2 (cg-RX-API-DMAC7.html)
CN (2) CN102946915B (cg-RX-API-DMAC7.html)
AU (1) AU2011258295B2 (cg-RX-API-DMAC7.html)
CA (2) CA2800284C (cg-RX-API-DMAC7.html)
WO (1) WO2011150055A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12570954B2 (en) 2020-09-04 2026-03-10 Annoviant, Inc. Systems and methods for processing tissue

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7905826B2 (en) * 2004-11-03 2011-03-15 Cook Incorporated Methods for modifying vascular vessel walls
WO2006062976A2 (en) 2004-12-07 2006-06-15 Cook Incorporated Methods for modifying vascular vessel walls
EP2901156B1 (en) * 2012-09-26 2018-06-20 Cook Biotech Incorporated Medical device design, manufacture and testing systems
US9498559B2 (en) * 2012-10-08 2016-11-22 Cormatrix Cardiovascular, Inc. Reinforced vascular protheses
US10280391B2 (en) * 2012-12-11 2019-05-07 Pall Technology Uk Limited Recipient for cell cultivation
JP6272647B2 (ja) * 2013-01-21 2018-01-31 テルモ株式会社 シート状細胞培養物の製造方法
KR102129562B1 (ko) * 2013-04-08 2020-07-03 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 결장절제없이 염증성 장 질환을 치료하는 방법 및 조성물
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
CN106137458B (zh) * 2015-04-24 2021-05-25 四川蓝光英诺生物科技股份有限公司 一种血管浇注成型装置及方法
WO2016191689A1 (en) * 2015-05-27 2016-12-01 Cook Regentec Llc Sheet-form cell growth scaffold particles and grafts, and methods for same
WO2017062762A2 (en) 2015-10-07 2017-04-13 Sigmon John C Methods, medical devices and kits for modifying the luminal profile of a body vessel
KR102170373B1 (ko) 2016-05-02 2020-10-27 인테그리컬쳐 인코포레이티드 성장 유도 시스템, 성장 유도 제어 장치, 성장 유도 제어 방법, 및 성장 유도 제어 프로그램
WO2018013727A1 (en) 2016-07-12 2018-01-18 Deka Products Limited Partnership System and method for applying force to a device
US11254901B2 (en) 2016-07-12 2022-02-22 Deka Products Limited Partnership System and method for printing tissue
CN107670145B (zh) * 2016-08-01 2021-09-14 北京唐颐惠康生物医学技术有限公司 一种干细胞专用输注泵及输注方法
US11299705B2 (en) 2016-11-07 2022-04-12 Deka Products Limited Partnership System and method for creating tissue
US10572011B2 (en) * 2017-06-30 2020-02-25 Microsoft Technology Licensing, Llc Haptic feedback system
US12297416B2 (en) 2017-07-12 2025-05-13 Deka Products Limited Partneship System and method for transferring tissue
US10570362B2 (en) * 2017-07-12 2020-02-25 Deka Products Limited Partnership System and method for transferring tissue
US20210085834A1 (en) * 2017-07-26 2021-03-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Multi-Layered Graft for Tissue Engineering Applications
JP6574274B2 (ja) * 2018-01-04 2019-09-11 テルモ株式会社 シート状細胞培養物の製造方法
SG11202112036YA (en) * 2019-05-02 2021-11-29 Aleph Farms Ltd Cultivation systems and methods for large-scale production of cultured food
WO2021097419A1 (en) * 2019-11-15 2021-05-20 Research Institute At Nationwide Children's Hospital Systems and methods producing seeded grafts
JP2021132541A (ja) * 2020-02-25 2021-09-13 テルモ株式会社 生体由来組織を細切するための方法
US11826490B1 (en) 2020-12-29 2023-11-28 Acell, Inc. Extracellular matrix sheet devices with improved mechanical properties and method of making
WO2026080590A1 (en) * 2024-10-11 2026-04-16 Integra Lifesciences Corporation Method and matrix for brain tissue repair

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004067733A1 (en) * 2003-01-31 2004-08-12 Himedica Limited Improvements in and relating to cell growth
US20050202058A1 (en) * 2002-05-02 2005-09-15 Hiles Michael C. Cell-seeded extracellular matrix grafts

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1807141A (en) 1928-09-15 1931-05-26 Alan D Wood Embossing metallic plates
US4458678A (en) 1981-10-26 1984-07-10 Massachusetts Institute Of Technology Cell-seeding procedures involving fibrous lattices
IL75554A (en) * 1985-06-18 1993-01-14 Yeda Res & Dev Matrix for cell cultivation in vitro
FR2597501B1 (fr) * 1986-04-18 1990-01-19 Merieux Inst Procede de fabrication de nappes de collagene, nappes obtenues et leurs applications
US5026650A (en) * 1988-06-30 1991-06-25 The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration Horizontally rotated cell culture system with a coaxial tubular oxygenator
JPH089961A (ja) 1994-06-30 1996-01-16 Sumitomo Bakelite Co Ltd 培養器およびその製造方法
US5518205A (en) 1994-09-06 1996-05-21 Rockwell International Corporation High altitude, long duration surveillance system
DE4438015A1 (de) * 1994-10-25 1996-05-02 Boehringer Mannheim Gmbh Epithelzellenhaltiges Biomaterial und dessen Verwendung als Transplantat
IL115728A0 (en) * 1994-10-25 1996-01-19 Boehringer Mannheim Gmbh Biomaterial containing epithelial cells and use thereof as a transplant
KR100650295B1 (ko) 1996-08-23 2006-11-28 쿠크 바이오텍, 인코포레이티드 조직이식기관, 조직이식물 및 조직이식방법
US6886568B2 (en) * 1998-04-08 2005-05-03 The Johns Hopkins University Method for fabricating cell-containing implants
US6866842B1 (en) 1998-05-01 2005-03-15 University Of Pittsburgh Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US6662805B2 (en) * 1999-03-24 2003-12-16 The Johns Hopkins University Method for composite cell-based implants
CA2378618C (en) * 1999-08-06 2009-10-06 Cook Biotech Incorporated Tubular graft construct
HUP0300810A2 (hu) 2000-07-20 2003-08-28 M.G.V.S. Ltd. Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
US6638312B2 (en) * 2000-08-04 2003-10-28 Depuy Orthopaedics, Inc. Reinforced small intestinal submucosa (SIS)
EP1325110A4 (en) * 2000-10-02 2009-03-25 Thomas F Cannon AUTOMATED BIOCULTURE AND BIOCULTURAL EXPERIENCE SYSTEM
AUPR298901A0 (en) * 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
US7155417B1 (en) 2001-06-05 2006-12-26 Intervoice Limited Partnership System and method for detecting fraud in prepaid accounts
US7651684B2 (en) 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US7595043B2 (en) 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US9144583B2 (en) 2002-03-29 2015-09-29 Tissue Genesis, Inc. Cell separation apparatus and methods of use
US8202725B2 (en) * 2004-12-23 2012-06-19 Tissue Genesis Incorporated Cell sodding method and apparatus
US8492140B2 (en) 2002-04-08 2013-07-23 Octane Biotech Inc. Automated tissue engineering system
MXPA04010667A (es) 2002-05-01 2005-07-01 Verigen Ag Implante inyectable de condrocitos.
US20030212456A1 (en) * 2002-05-09 2003-11-13 John Lipchitz Implant for tissue repair
WO2005020847A2 (en) 2003-08-25 2005-03-10 Cook Biotech Incorporated Graft materials containing bioactive substances, and methods for their manufacture
AU2004270239C1 (en) * 2003-09-04 2011-07-07 Cook Biotech Incorporated Extracellular matrix composite materials, and manufacture and use thereof
US20050266556A1 (en) 2004-02-09 2005-12-01 Yoder Mervin C Isolation, expansion and use of clonogenic endothelial progenitor cells
US8808352B2 (en) * 2004-02-09 2014-08-19 Cook Medical Technologies Llc Cast bioremodelable graft
WO2006019043A1 (ja) * 2004-08-17 2006-02-23 Kyushu Institute Of Technology 細胞培養用多孔性シート状物とそれを用いたバイオリアクター及び培養方法
WO2006028274A1 (ja) * 2004-09-08 2006-03-16 National University Corporation Nagoya University 細胞培養物の生産と該生産に用いる材料
CN101141987B (zh) * 2005-02-23 2012-09-19 Hi-Lex株式会社 医用材料、人工牙根及医疗材料的制造方法
US9788821B2 (en) 2005-04-29 2017-10-17 Cook Biotech Incorporated Physically modified extracellular matrix materials and uses thereof
CN100477971C (zh) * 2005-05-27 2009-04-15 中国人民解放军总医院 一种关节软骨原性微载体
US8932620B2 (en) * 2005-06-17 2015-01-13 Drexel University Three-dimensional scaffolds for tissue engineering made by processing complex extracts of natural extracellular matrices
AU2006268129A1 (en) 2005-07-12 2007-01-18 Tissue Genesis, Inc. Apparatus and methods for preparing tissue grafts
WO2007016122A2 (en) * 2005-07-27 2007-02-08 Cook Incorporated Implantable remodelable materials comprising magnetic material
US20070048383A1 (en) * 2005-08-25 2007-03-01 Helmus Michael N Self-assembled endovascular structures
US8053559B2 (en) * 2005-10-27 2011-11-08 Coloplast A/S Biodegradable scaffold with ECM material
EP1988152B1 (en) * 2006-02-21 2016-11-23 JSR Corporation Cell culture construct, cell culture container, construct having spheroid, container having spheroid and method of producing the same
US8003388B2 (en) * 2006-03-24 2011-08-23 Nortis, Inc. Method for creating perfusable microvessel systems
US20070269476A1 (en) * 2006-05-16 2007-11-22 Voytik-Harbin Sherry L Engineered extracellular matrices control stem cell behavior
CN106390200A (zh) 2006-10-23 2017-02-15 库克生物科技公司 组分特性增强的处理的ecm材料
ES2524443T3 (es) 2006-11-13 2014-12-09 DePuy Synthes Products, LLC Expansión in vitro de células postparto usando microportadores
US20080112998A1 (en) * 2006-11-14 2008-05-15 Hongjun Wang Innovative bottom-up cell assembly approach to three-dimensional tissue formation using nano-or micro-fibers
WO2008124229A2 (en) * 2007-04-06 2008-10-16 Caridianbct, Inc. Improved bioreactor surfaces
US20100136645A1 (en) * 2007-04-17 2010-06-03 Byoung-Hyun Min Method for preparing a cell-derived extracellular matrix scaffold
US20080279833A1 (en) * 2007-05-10 2008-11-13 Matheny Robert G Laminate sheet articles for tissue regeneration
AU2008265850B2 (en) * 2007-06-15 2014-06-26 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
JP2009055817A (ja) 2007-08-30 2009-03-19 Tokai Univ 細胞運命の解析方法
EP2058662A1 (en) 2007-10-17 2009-05-13 Koninklijke Philips Electronics N.V. Diagnosis of diseases by measuring cell mediated extracellular matrix degradation
US8309342B2 (en) 2007-12-04 2012-11-13 Ingeneron, Inc. Apparatus and methods for cell isolation
WO2009076391A2 (en) * 2007-12-10 2009-06-18 Cook Biotech Incorporated Medical materials including modified extracellular matrix materials
US20090163990A1 (en) 2007-12-19 2009-06-25 Chunlin Yang Decellularized omentum matrix and uses thereof
WO2009086499A2 (en) * 2007-12-28 2009-07-09 Cook Biotech Incorporated Medical composition including an extracellular matrix particulate
CN101195044A (zh) * 2007-12-29 2008-06-11 中国人民解放军第四军医大学 一种组织工程化微粒组织及其制备方法
FR2927632B1 (fr) * 2008-02-14 2013-07-19 Basf Beauty Care Solutions F Cornee et muqueuse reconstruites.
WO2009116951A2 (en) 2008-03-17 2009-09-24 Agency For Science, Technology And Research Microcarriers for stem cell culture
JP2011516462A (ja) 2008-04-03 2011-05-26 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 磁性粒子イメージング用生体適合物
CN101597633B (zh) * 2008-06-03 2012-08-22 哈药集团生物工程有限公司 一种新的细胞悬浮培养生产重组人促红细胞生成素的方法
DE102012105540A1 (de) * 2012-06-26 2014-04-24 Karlsruher Institut für Technologie Gefäßmodell, Verfahren zu seiner Herstellung und seine Verwendung

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050202058A1 (en) * 2002-05-02 2005-09-15 Hiles Michael C. Cell-seeded extracellular matrix grafts
WO2004067733A1 (en) * 2003-01-31 2004-08-12 Himedica Limited Improvements in and relating to cell growth

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12570954B2 (en) 2020-09-04 2026-03-10 Annoviant, Inc. Systems and methods for processing tissue

Also Published As

Publication number Publication date
US20110319868A1 (en) 2011-12-29
CA3071304A1 (en) 2011-12-01
JP2018113994A (ja) 2018-07-26
US11077231B2 (en) 2021-08-03
EP2575913B1 (en) 2018-07-25
US20160082157A1 (en) 2016-03-24
EP3443991A1 (en) 2019-02-20
JP2013528072A (ja) 2013-07-08
JP6794398B2 (ja) 2020-12-02
CA3071304C (en) 2023-09-05
WO2011150055A3 (en) 2012-07-12
CN105311677B (zh) 2019-08-20
AU2011258295A1 (en) 2013-01-10
WO2011150055A2 (en) 2011-12-01
CN102946915B (zh) 2015-12-09
US12121631B2 (en) 2024-10-22
US20190117843A1 (en) 2019-04-25
JP5947790B2 (ja) 2016-07-06
CN102946915A (zh) 2013-02-27
US10071187B2 (en) 2018-09-11
US20150359940A1 (en) 2015-12-17
US11173231B2 (en) 2021-11-16
US9115336B2 (en) 2015-08-25
CN105311677A (zh) 2016-02-10
US20220280696A1 (en) 2022-09-08
CA2800284A1 (en) 2011-12-01
CA2800284C (en) 2020-02-11
EP2575913A2 (en) 2013-04-10
JP2016105726A (ja) 2016-06-16
JP6336499B2 (ja) 2018-06-06

Similar Documents

Publication Publication Date Title
US12121631B2 (en) Methods, substrates, and systems useful for cell seeding of medical grafts
TWI544073B (zh) 細胞分離裝置及使用方法
Bijonowski et al. Bioreactor design for perfusion-based, highly vascularized organ regeneration
US9931439B2 (en) Modifiable medical grafts and related methods and apparatuses
US20210338816A1 (en) Magnetic Delivery System and Hydrogel Fixative for Therapeutic Cells
JP2009501562A (ja) 組織移植片を前処理する装置および方法
CN101258237A (zh) 用于制备组织移植物的装置和方法
AU2015202093B2 (en) Methods, substrates, and systems useful for cell seeding of medical grafts
JP6158821B2 (ja) 修飾可能な医療用移植片ならびに関連する方法および機器

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: MUFFIN INCORPORATED; COOK BIOTECH INCORPORATED

Free format text: FORMER APPLICANT(S): COOK BIOTECH INCORPORATED; COOK MEDICAL TECHNOLOGIES LLC; MUFFIN INCORPORATED

FGA Letters patent sealed or granted (standard patent)